Related Experiment Video
Updated: Jun 9, 2026
06:28
Screening Cotton Genotypes for Reniform Nematode Resistance
Published on: May 2, 2019
Anthelmintic resistance: markers for resistance, or susceptibility?
R N Beech1, P Skuce, D J Bartley
1Institute of Parasitology, Macdonald College, McGill University, Ste Anne de Bellevue, QC H9X3V9, Canada. robin.beech@mcgill.ca
Parasitology
|September 10, 2010
Summary
Anthelmintic resistance in parasitic nematodes is a growing concern, driven by genetic changes like beta-tubulin substitutions. Understanding these resistance mechanisms is crucial for effective treatment strategies.
Area of Science:
- Veterinary Parasitology
- Molecular Biology
- Drug Resistance
Background:
- Anthelmintic resistance poses a significant threat to animal health and agricultural productivity.
- The Consortium for Anthelmintic Resistance and Susceptibility (CARS) aims to advance knowledge and detection of resistance.
- Shared resistance mechanisms across different anthelmintic drug classes are increasingly recognized.
Purpose of the Study:
- To review current knowledge on anthelmintic resistance mechanisms in parasitic nematodes.
- To highlight shared features of resistance across various anthelmintic drug classes.
- To discuss detection methods and treatment strategies for anthelmintic resistance.
Main Methods:
- Review of scientific literature on anthelmintic resistance.
- Analysis of genetic and molecular mechanisms underlying resistance.
- Discussion of diagnostic tools and databases for resistance monitoring.
Main Results:
- Benzimidazole resistance is linked to specific beta-tubulin amino acid substitutions.
- Changes in gene expression, such as increased P-glycoprotein, contribute to resistance.
- While laboratory studies show ion-channel mutations in resistance, field evidence is limited.
Conclusions:
- Anthelmintic resistance involves both the loss of drug sensitivity and the emergence of resistance.
- Coordinated research efforts using genetic analysis tools and databases are essential.
- Monitoring anthelmintic susceptibility is as critical as detecting resistance.
More Related Videos
Related Concept Videos
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...